CANNABINOID COMPOSITIONS AGAINST CANCER, THEIR IDENTIFICATION AND PERSONALIZATION OF CANNABIS-BASED CANCER THERAPY
卷宗概要
发明人
Jan ROŽANC; Marko MILOJEVIC; Marko JUKIC; Urban BREN; Uroš MAVER
IPC 分类
CPC 分类
In a first aspect, the invention pertains to a method for identifying a therapeutic composition against cancer comprising at least one cannabinoid. It is based on a holistic approach that relies on determining its therapeutic efficacy of a composition comprising at least one cannabinoid and by performing a computational analysis on the resulting data. In additional aspects, the invention pertains to therapeutic compositions comprising at least one cannabinoid and their use for the treatment of a condition or disease. Furthermore, the invention pertains to an in-vitro method for the personalization of-based therapy. Said method relies on providing a patient sample and performing a multiomic analysis on said patient sample. After predicting the patient's response to a therapeutic composition comprising at least one cannabinoid, a therapeutic composition comprising at least one cannabinoid is selected for treatment of the patient.
原文(中文)
In a first aspect, the invention pertains to a method for identifying a therapeutic composition against cancer comprising at least one cannabinoid. It is based on a holistic approach that relies on determining its therapeutic efficacy of a composition comprising at least one cannabinoid and by performing a computational analysis on the resulting data. In additional aspects, the invention pertains to therapeutic compositions comprising at least one cannabinoid and their use for the treatment of a condition or disease. Furthermore, the invention pertains to an in-vitro method for the personalization of-based therapy. Said method relies on providing a patient sample and performing a multiomic analysis on said patient sample. After predicting the patient's response to a therapeutic composition comprising at least one cannabinoid, a therapeutic composition comprising at least one cannabinoid is selected for treatment of the patient.